CYTAVIS BIOPHARMA GMBH has a total of 11 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are MELEMA PHARMA GMBH, THERAPIX BIOSCIENCES LTD and MEHTA NOZER M.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | Germany | 1 | |
#5 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Lentzen Hans | 10 |
#2 | Witthohn Klaus | 9 |
#3 | Eck Jurgen | 1 |
#4 | Zinke Holger | 1 |
#5 | Witthohn Klaus Dr | 1 |
#6 | Schmidt Arno | 1 |
Publication | Filing date | Title |
---|---|---|
EP2508195A1 | Medicine containing recombinant mistellectins for treating malignant melanoma | |
DE102011003478A1 | Antiviral agent containing recombinant mistletoe lectins |